STOCK TITAN
  1. Home
  2. News
  3. UCBJY

UCB SA - UCBJY STOCK NEWS

IMPACT
SENTIMENT
UCBJY : OTC
UCB presents late-breaking posters at Child Neurology Society Meeting
IMPACT
SENTIMENT
UCBJY : OTC
UCB announces U.S. availability of RYSTIGGO® (rozanolixizumab-noli) for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
IMPACT
SENTIMENT
UCBJY : OTC
UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis
fda approval
IMPACT
SENTIMENT
UCBJY : OTC
UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting
IMPACT
SENTIMENT
UCBJY : OTC
UCB Announces FINTEPLA® (fenfluramine) Oral Solution Is Now Descheduled and Is No Longer Listed as a Controlled Substance
IMPACT
SENTIMENT
UCBJY : OTC
Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks
clinical trial
IMPACT
SENTIMENT
UCBJY : OTC
UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis, and Hidradenitis Suppurativa
conferences
IMPACT
SENTIMENT
UCBJY : OTC
Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis
clinical trial
IMPACT
SENTIMENT
UCBJY : OTC
UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review
IMPACT
SENTIMENT
UCBJY : OTC
UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa
clinical trial
Stock UCBJY logo
UCB SA

OTC:UCBJY

UCBJY Rankings

#794 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

UCBJY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Pharmaceuticals: Major, Health Technology, Manufacturing, Medicinal and Botanical Manufacturing
Belgium
Anderlecht